BriaCell Therapeutics Corp. reports

Company location: West Vancouver, British Columbia, Canada
Fiscal year end: 31 July

BriaCell Therapeutics Corp. has filed 323 SEC EDGAR filings since 20 Jun 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
40-F
6-K

SEC filing history

Showing 251-275 of 323 matching filings.

Per page

Current page

CORRESP

CORRESP filing

Filing date: 22 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 21 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 16 Jun 2021
Reporting date: 16 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

D File 021-403035

D filing

Filing date: 15 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

F-1 File 333-257104

F-1 filing

Filing date: 15 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G File 005-92289

SC 13G

Filing date: 14 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 10 Jun 2021
Reporting date: 10 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 09 Jun 2021
Reporting date: 09 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 08 Jun 2021
Reporting date: 08 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 04 Jun 2021
Reporting date: 04 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 02 Jun 2021
Reporting date: 02 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 20 May 2021
Reporting date: 19 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 11 May 2021
Reporting date: 11 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 27 Apr 2021
Reporting date: 27 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 16 Apr 2021
Reporting date: 16 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 12 Apr 2021
Reporting date: 12 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 01 Apr 2021
Reporting date: 01 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-40101

6-K filing

Filing date: 31 Mar 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-92289

ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date: 08 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-92289

SC 13G filing

Filing date: 05 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-92289

SABBY 13G BCTX

Filing date: 03 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-92289